MedPath

Green Tea Extracts for Mild-to-moderate Diabetic Peripheral Neuropathy

Not Applicable
Completed
Conditions
Diabetic Peripheral Neuropathy
Registration Number
NCT04543422
Lead Sponsor
Egyptian Biomedical Research Network
Brief Summary

the present randomized placebo-controlled study aimed to evaluate the effect of green tea extract administration on the clinical and neurophysiological parameters in patients with mild-to-moderate diabetic peripheral neuropathy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Diabetic patients with peripheral neuropathy
Exclusion Criteria
  • Patients under treatment of diabetic peripheral neuropathy.
  • Patients with other causes of peripheral neuropathy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Toronto Clinical Scoring Systemthree months

Improvement describes the difference between baseline and post-intervention outcome parameters

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Al-Azhar University Faculty of Medicine

🇪🇬

Cairo, Egypt

Al-Azhar University Faculty of Medicine
🇪🇬Cairo, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.